Zantac being pulled over contamination issue

September 18, 2019 05:23 PM

Zantac is being pulled off the market.

The drug's manufacturer has decided to halt distribution of the antacid until a contamination issue is resolved.

Advertisement – Content Continues Below

As NewsChannel 13 previously reported, the FDA said some lots of ranitidine were found to contain small amounts of an NDMA, considered to be a human carcinogen.

Patients who wish the switch to another medication should talk to their doctor.


WNYT Staff

Copyright 2019 WNYT-TV LLC, a Hubbard Broadcasting Company. All rights reserved

Pence announces Turkey has agreed to cease-fire in Syria

Troy video appears to show tractor trailer passing stopped school bus

Powerful Democratic Congressman Elijah Cummings has died

Sycamore Motel owner to pay $1,000 fine

US envoy says Giuliani was given role on Ukraine policy